Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia
Journal
Redox Biology
Publication Date
11-1-2023
Volume
67
First Page
102901
Document Type
Open Access Publication
DOI
10.1016/j.redox.2023.102901
Rights and Permissions
Paiboonrungruang C, Xiong Z, Lamson D, Li Y, Bowman B, Chembo J, Huang C, Li J, Livingston EW, Frank JE, Chen V, Li Y, Weissman B, Yuan H, Williams KP, Ben Major M, Chen X. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia. Redox Biol. 2023 Nov;67:102901. doi: 10.1016/j.redox.2023.102901. © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Recommended Citation
Paiboonrungruang, Chorlada; Bowman, Brittany; Chembo, Julius; Ben Major, M; and et al., "Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia." Redox Biology. 67, 102901 (2023).
https://digitalcommons.wustl.edu/oa_4/2870
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
